Concepedia

Gino Beggiolin

GB

Statistics

Publications

11

Citations

483

H-Index

11

Active since

1981

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Vermont

Roche (United States)

Tumori Foundation

Gino Beggiolin is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in cancer pharmacology, medicine, and chemotherapy.

Publications per year

1981–2003

11

Publications

11

A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.

Paola Perego, Michelandrea De Cesare, P De Isabella et al. · PubMed · 2001 · 83 citations

, , +14

Bbr 2778, an Aza-anthracenedione Endowed with Preclinical Anticancer Activity and Lack of Delayed Cardiotoxicity

Gino Beggiolin, Luca Crippa, Ernesto Menta et al. · Tumori Journal · 2001 · 65 citations

, , +13

Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines

John D. Roberts, John Peroutka, Gino Beggiolin et al. · Journal of Inorganic Biochemistry · 1999 · 65 citations

, , +9

Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.

P. Di Blasi, A. Bernareggi, Gino Beggiolin et al. · PubMed · 1998 · 56 citations

, , +13

Synthesis and Antitumor Evaluation of 2,5-Disubstituted- Indazolo[4,3-<i>g</i><i>h</i>]isoquinolin-6(2<i>H</i>)-ones (9-Aza-anthrapyrazoles)

A. Paul Krapcho, Ernesto Menta, Ambrogio Oliva et al. · Journal of Medicinal Chemistry · 1998 · 52 citations

, , +13

1–5 of 11